Panelists discuss how significant gaps in current uncomplicated urinary tract infection (UTI) therapies include insufficient nonantibiotic preventive strategies, limited options for multidrug ...

Gepotidacin is an oral, first-in-class triazaacenaphthylene antibiotic that inhibits bacterial DNA replication by blocking 2 different type II topoisomerase enzymes. Study participants were ...

The Food and Drug Administration has approved a new antibiotic that can treat uncomplicated urinary tract infections, or uUTIs, successfully and safely. Gepotidacin will be marketed under the ...

The FDA approved gepotidacin for the treatment of uncomplicated UTIs in women and adolescent girls aged 12 years or older, GSK announced. It is the first new antibiotic for the treatment of ...

The approval of gepotidacin (Blujepa; GSK) introduces the first new class of oral antibiotics for uncomplicated urinary tract infections (UTIs) in nearly 30 years. More than half of all women ...

Nasal fractures account for over 50% of all facial fractures in adults. Recognizing the symptoms of a broken nose can help ensure you receive appropriate treatment. How to Tell If Your Nose Is Broken ...

A day after he was struck in the face by a pitch, Nationals third baseman Paul DeJong was placed on the 10-day injured list ...

Protein is essential for bone structure.It helps in the formation of bone tissues and also supports muscle strength, which reduces the risk of falls and fractures. Good protein sources: Eggs, fish ...

Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window The FDA approved oral gepotidacin (Blujepa) for uncomplicated urinary tract infections (UTIs) in women and girls ages ...

March 26, 2025 — The FDA has approved a new medication to treat uncomplicated urinary tract infections in women and girls aged 12 or older. It is the first in a new class of oral antibiotics ...

Blujepa is approved to treat females 12 and older with uncomplicated urinary tract infections, or UTIs. About half of all women will experience a UTI at some point in their lives, and about 30% ...